Risultati della ricerca - Markus Graefen
- Mostra 1 - 20 risultati su 72
- Vai alla pagina seguente
-
1
-
2
-
3
-
4
Size of lymph-node metastases in prostate cancer patients undergoing radical prostatectomy: implication for imaging and oncologic follow-up of 2705 lymph-node positive patients di Fabian Falkenbach, Mykyta Kachanov, Sami‐Ramzi Leyh‐Bannurah, Tobias Maurer, Sophie Knipper, Daniel Köhler, Markus Graefen, Guido Sauter, Lars Budäus
Pubblicazione 2024Artigo -
5
Postoperative complications of contemporary open and robot‐assisted laparoscopic radical prostatectomy using standardised reporting systems di Raisa S. Pompe, Burkhard Beyer, Alexander Haese, Felix Preißer, Uwe Michl, Thomas Steuber, Markus Graefen, Hartwig Huland, Pierre I. Karakiewicz, Derya Tilki
Pubblicazione 2018Artigo -
6
-
7
Objective assessment of intraoperative skills for robot‐assisted radical prostatectomy (RARP): results from the ERUS Scientific and Educational Working Groups Metrics Initiative di Alexandre Mottrie, Elio Mazzone, Peter Wiklund, Markus Graefen, Justin Collins, Ruben De Groote, Paolo Dell′Oglio, Stefano Puliatti, Anthony G. Gallagher
Pubblicazione 2020Artigo -
8
-
9
Critical assessment of tools to predict clinically insignificant prostate cancer at radical prostatectomy in contemporary men di Felix K.‐H. Chun, Alexander Haese, Sascha Ahyai, Jochen Walz, Nazareno Suardi, Umberto Capitanio, Markus Graefen, Andreas Erbersdobler, Hartwig Huland, Pierre I. Karakiewicz
Pubblicazione 2008Artigo -
10
The impact of androgen‐deprivation therapy (<scp>ADT</scp>) on the risk of cardiovascular (<scp>CV</scp>) events in patients with non‐metastatic prostate cancer: a population‐based... di Giorgio Gandaglia, Maxine Sun, Ioana Popa, Jonas Schiffmann, Firas Abdollah, Quoc‐Dien Trinh, Fred Saad, Markus Graefen, Alberto Briganti, Francesco Montorsi, Pierre I. Karakiewicz
Pubblicazione 2014Artigo -
11
Currently used criteria for active surveillance in men with low‐risk prostate cancer di Nazareno Suardi, Umberto Capitanio, Felix K.‐H. Chun, Markus Graefen, Paul Perrotte, Thorsten Schlomm, Alexander Haese, Hartwig Huland, Andreas Erbersdobler, Francesco Montorsi, Pierre I. Karakiewicz
Pubblicazione 2008Artigo -
12
-
13
DEVELOPMENT AND VALIDATION OF A NOMOGRAM PREDICTING THE OUTCOME OF PROSTATE BIOPSY BASED ON PATIENT AGE, DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE SPECIFIC ANTIGEN di Pierre I. Karakiewicz, Serge Benayoun, Michael W. Kattan, Paul Perrotte, Luc Valiquette, Peter T. Scardino, Ilias Cagiannos, Hans Heinzer, Simon Tanguay, Armen Aprikian, Hartwig Huland, Markus Graefen
Pubblicazione 2005Artigo -
14
Marked heterogeneity of ERG expression in large primary prostate cancers di Sarah Minner, Michael Gärtner, Fabian Freudenthaler, Melanie Bauer, Martina Kluth, Georg Salomon, Hans Heinzer, Markus Graefen, Carsten Bokemeyer, Ronald Simon, Guido Sauter, Thorsten Schlomm, Waldemar Wilczak
Pubblicazione 2012Artigo -
15
Minimal-Invasive Robot-Assisted Image-Guided Resection of Prostate-Specific Membrane Antigen–Positive Lymph Nodes in Recurrent Prostate Cancer di Fijs W. B. van Leeuwen, Matthias N. van Oosterom, P. Meershoek, Pim J. van Leeuwen, Christoph Berliner, Henk G. van der Poel, Markus Graefen, Tobias Maurer
Pubblicazione 2019Artigo -
16
Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death di Derya Tilki, Ming‐Hui Chen, Jing Wu, Hartwig Huland, Markus Graefen, Osama Mohamad, Janet E. Cowan, Felix Y. Feng, Peter R. Carroll, Anthony V. D’Amico
Pubblicazione 2023Artigo -
17
Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy di Mike Wenzel, Benedikt Hoeh, Carolin Siech, Florestan Koll, Clara Humke, Daniel Groener, Thomas Steuber, Markus Graefen, Tobias Maurer, Séverine Banek, Felix K.‐H. Chun, Philipp Mandel
Pubblicazione 2025Artigo -
18
Treatment of the Primary Tumor in Metastatic Prostate Cancer: Current Concepts and Future Perspectives di Christopher E. Bayne, Stephen B. Williams, Matthew R. Cooperberg, Martin Gleave, Markus Graefen, Francesco Montorsi, Giacomo Novara, Marc C. Smaldone, Prasanna Sooriakumaran, Peter Wiklund, Brian F. Chapin
Pubblicazione 2015Revisão -
19
The polyphosphate–factor XII pathway drives coagulation in prostate cancer-associated thrombosis di Katrin F. Nickel, G. Ronquist, Florian Länger, Linda Labberton, Tobias A. Fuchs, Carsten Bokemeyer, Guido Sauter, Markus Graefen, Nigel Mackman, Evi X. Stavrou, Gunnar Ronquist, Thomas Renné
Pubblicazione 2015Artigo -
20
Retropubic, Laparoscopic, and Robot-Assisted Radical Prostatectomy: A Systematic Review and Cumulative Analysis of Comparative Studies di Vincenzo Ficarra, Giacomo Novara, Walter Artibani, Andrea Cestari, Antonio Galfano, Markus Graefen, Giorgio Guazzoni, Bertrand Guillonneau, Mani Menon, Francesco Montorsi, Vipul Patel, Jens Rassweiler, Hendrik Van Poppel
Pubblicazione 2009Revisão
Strumenti per la ricerca:
Soggetti correlati
Cancer
Medicine
Prostate cancer
Internal medicine
Oncology
Prostate
Prostatectomy
Urology
Biology
Cancer research
Genetics
Surgery
Pathology
Apoptosis
Gene
Biochemical recurrence
Disease
PI3K/AKT/mTOR pathway
PTEN
Prostate-specific antigen
Tissue microarray
Cohort
Immunohistochemistry
Coronavirus disease 2019 (COVID-19)
Erg
Gynecology
Infectious disease (medical specialty)
Adverse effect
Androgen deprivation therapy
Proportional hazards model